Breast Cancer Clinical Trial
Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
Summary
The primary purpose of this research is to analyze the cells present in the fluid obtained via ductal lavage from the nipple of a woman with a known diagnosis of breast cancer. A portion of the lavage fluid may be used in future breast cancer biomarkers. Remaining lavage fluid will be used to analyze its biochemical composition, for investigational purposes only.
Eligibility Criteria
Inclusion Criteria:
18 years of age
biopsy-proven unilateral invasive breast cancer of any histology or ductal carcinoma in situ
patient desires or requires treatment with mastectomy
any patient who has undergone prior excisional biopsy of their primary breast tumor must have had margins positive for disease, or must have either mammographic or ultrasonographic evidence of probable residual disease in the breast.
patients receiving induction chemotherapy remain eligible for participation in the study regardless of tumor response; those with a clinical complete response remain eligible.
voluntarily signed informed consent. -
Exclusion Criteria:
male gender
lobular carcinoma in situ as the only cancerous histology
prior margin-negative excisional biopsy of primary breast tumor, with no evidence of residual disease
patient being treated with breast conservation therapy inability to understand the nature of the procedure pregnancy and/or active lactation
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Ann Arbor Michigan, 48109, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.